Research shows that fiber reduces hunger and promotes satiety through several gastrointestinal mechanisms
Semaglutide is FDA-approved for adolescents 12 and older for obesity, and tirzepatide is approved for adolescents 10 and older for Type 2 diabetes
They require caution in severe renal or hepatic impairment and in patients with a history of acute pancreatitis
Metformin is not FDA-approved for weight loss.
Obes Sci Amp Pract (2019) 5:36675
Related PDB-101 Resources Browse Drug Action Browse You and Your Health Browse Diabetes Browse Biomolecular Structural Biology References 6LN2: Wu F, Yang L, Hang K, Laursen M, Wu L, Han GW, Ren Q, Roed NK, Lin G, Hanson MA, Jiang H, Wang MW, Reedtz-Runge S, Song G, Stevens RC